Defensin Antibodies

Santa Cruz Biotechnology features a diverse variety of Defensin Antibodies for investigating defensins in immune response and host defense mechanisms. Defensin Antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA).Defensins are small cationic peptides that play a crucial role in the innate immune system, exhibiting antimicrobial activity against a wide range of pathogens. They are essential for the first line of defense, contributing to the regulation of inflammation and the modulation of adaptive immune responses. Understanding defensin function is vital for developing therapeutic strategies against infections and inflammatory diseases. Defensin research has revealed significant insights into antimicrobial mechanisms and immune system regulation. Current studies focus on exploring defensin expression patterns in various tissues and their response to different pathogenic challenges. Ongoing research continues to uncover new aspects of defensin-mediated protection and their potential therapeutic applications. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing our understanding of defensin biology and its implications for human health.